Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial

被引:0
|
作者
Soufila KT
Vishal Thakur
Tarun Narang
Sunil Dogra
Sanjeev Handa
机构
[1] Postgraduate Institute of Medical Education and Research,Department of Dermatology, Venereology and Leprology
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:415 / 423
页数:8
相关论文
共 50 条
  • [21] Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial
    Navarro-Lopez, Vicente
    Martinez-Andres, Asuncion
    Ramirez-Bosca, Ana
    Ruzafa-Costas, Beatriz
    Nunez-Delegido, Eva
    Carrion-Gutierrez, Miguel A.
    Prieto-Merino, David
    Codoner-Cortes, Francisco
    Ramon-Vidal, Daniel
    Genoves-Martinez, Salvador
    Chenoll-Cuadros, Empar
    Perez-Orquin, Jose M.
    Pico-Monllor, Jose A.
    Chumillas-Lidon, Sara
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (12) : 1078 - 1084
  • [22] Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
    Gold, Linda Stein
    Papp, Kim
    Pariser, David
    Green, Lawrence
    Bhatia, Neal
    Sofen, Howard
    Albrecht, Lorne
    Gooderham, Melinda
    Chen, Mindy
    Paris, Maria
    Wang, Yao
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 77 - 85
  • [23] Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)
    Joydeep Samanta
    GSRSNK Naidu
    Arghya Chattopadhyay
    Amal Basnet
    Tarun Narang
    Varun Dhir
    Sunil Dogra
    Sanjay Jain
    Aman Sharma
    Rheumatology International, 2023, 43 : 841 - 848
  • [24] COMPARISON BETWEEN METHOTREXATE AND APREMILAST IN PSORIATIC ARTHRITIS-A SINGLE BLINDED RANDOMIZED CONTROLLED TRIAL (APREMEPsA STUDY)
    Samanta, J.
    Naidu, G.
    Chattopadhyay, A.
    Basnet, A.
    Narang, T.
    Dogra, S.
    Sharma, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1305 - 1306
  • [25] Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial
    Duffin, Kristina Callis
    Gold, Linda Stein
    Leonardi, Craig
    Pariser, David
    Green, Lawrence
    Sofen, Howard
    Strober, Bruce
    Chen, Mindy
    Wang, Yao
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB83 - AB83
  • [26] Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)
    Samanta, Joydeep
    Naidu, G. S. R. S. N. K.
    Chattopadhyay, Arghya
    Basnet, Amal
    Narang, Tarun
    Dhir, Varun
    Dogra, Sunil
    Jain, Sanjay
    Sharma, Aman
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (5) : 841 - 848
  • [27] Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis
    Prussick, Ronald
    Unnebrink, Kristina
    Valdecantos, Wendell C.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 864 - 868
  • [28] Apremilast in patients with moderate to severe psoriasis: Results of a phase 3, randomized, controlled trial (ESTEEM 2)
    Mrowietz, U.
    Paul, C.
    Gooderham, M.
    Cather, J.
    Poulin, Y.
    Girolomoni, G.
    Ferrandiz, C.
    Gottlieb, A.
    Hu, C. C.
    Day, R.
    Crowley, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 93 - 94
  • [29] Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial
    Duan, Xin-Wang
    Zhang, Xiu-Ling
    Mao, Shao-Yuan
    Shang, Jing-Jing
    Shi, Xiao-Dong
    CLINICAL RHEUMATOLOGY, 2015, 34 (09) : 1513 - 1519
  • [30] Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial
    Xin-Wang Duan
    Xiu-Ling Zhang
    Shao-Yuan Mao
    Jing-Jing Shang
    Xiao-Dong Shi
    Clinical Rheumatology, 2015, 34 : 1513 - 1519